The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

Zhongsheng Pharmaceutical reports 22.28% revenue decline in first nine months of 2026

Oct 30, 2026 11:05 (4h ago)

Verifying

Zhongsheng Pharmaceutical released its 2026 third-quarter report on October 29.
Revenue reached CNY 1.468 billion, down 22.28% year-on-year.
Shareholder-attributable net profit totaled CNY 177 million during the first nine months.